3rd Annual NASH Summit, April 22-25, 2019, Boston, MA (description)


Address:1 Hotel Dr MA Boston, Massachusetts, United States of America 02128
Phone:+1 617 455 4188
Event dates:4/22/2019 - 4/25/2019
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 3rd Annual NASH Summit, April 22-25, 2019, Boston, MA


Topics to be Covered:

  • Adil Mardinoglu Professor of Systems Biology Kings College London, Allison Capone Global Strategic Marketing for Nonalcoholic Steatohepatitis Intercept, Anthony Samir Assistant Professor Harvard Medical School, Brent Tetri Director, Division of Gastroenterology & Hepatology, Professor of Internal Medicine Saint Louis University School of Medicine, Bryan Burkey Head of Pharmacology Zafgen, Bryan Fuchs Assistant in Molecular Biology Massachusetts General Hospital, Claus Kremoser Chief Executive Officer Phenex Pharmaceuticals, Dean Hum Senior Executive Vice President & Chief Scientific Officer Genfit, Diane Harbison Chief Executive Officer Stratified Medicine Scotland Innovation Centre, David Fraser Chief Scientific Officer NorthSea Therapeutics, Éric Lefebvre Chief Medical Officer Pliant Therapeutics, Etienne Sokal Chief Scientific & Medical Officer Promethera Biosciences, Glenn Rosen Independent Consultant, Greg Everson Chief Executive Officer HepQuant, Greg Tesz Principal Scientist Pfizer, H. James Harwood Adjunct Professor Department of Pathology Wake Forest University School of Medicine, Isai Peimer Biotech Analyst Surveyor Capital, Jagpreet Chhatwal Assistant Professor Harvard Medical School, James Conway Senior Scientist-Translational Bioinformatics MedImmune, Jelena Mann Professor of Epigenetics, Fibrosis Research Group Newcastle University, Jen-Chieh (Jay) Chuang Nonalcoholic Steatohepatitis, Fibrotic Diseases, Biomarker Sciences & Research Scientist Gilead, Jeff Irelan Director, Scientific Application Organovo, Julia Brosnan Senior Director, External Collaborations & Scientific Alliances Pfizer, Katie Brown Vice President, Support & Survivorship Program Lungevity (NASH Patient), Laura Brattain Research Scientist, Department of Radiology Massachusetts General Hospital, Laurent Fischer Senior Vice President Head Liver Therapeutic Area Allergan, Liat Hayardeny Chief Scientific Officer Galmed Pharmaceuticals, Linda Morrow Vice President & Chief Medical Officer ProSciento, Maria-Chiara Magnone Vice President, Metabolic Complications Janssen Research & Development, Marko Korenjak Vice President European Liver Patients Association, Manu Chakravarthy Chief Medical Officer & Senior Vice President Axcella Health, Matthews Bradley Founder, Chairman, President & Chief Technical Officer SAJE Pharma, Min Lu Director, Head of Fibrosis Morphic Therapeutics, Naim Alkhouri Director of the Metabolic Health Center Texas Liver Institute, Nikolai Naoumov Executive Director, Hepatology Sciences & Innovation Novartis, Patrick Horn Chief Medical Officer Albireo Pharmaceuticals, Pascal Prigent Executive Vice President, Commercial Genfit, Peter Guzzo Cofounder & Chief Executive Officer ConSynance Therapeutics, Peter Caravan Director of the Institute for Innovation in Imaging Massachusetts General Hospital, Peter Traber Partner Alacrita Consulting, Pietro Scalfaro Chief Medical Officer Enyo Pharma, Pnina Fishman Chief Executive Officer CanFite BioPharma, Rebecca Taub Chief Medical Officer, Executive Vice President Research & Development Madrigal Pharmaceuticals, Richard Lee Director Ionis Pharmaceuticals, Richard Torstenson Independent Regulatory Advisor, Ritesh Shah Commercial Development Lead, Internal Medicine Pfizer, Robert Arch Executive Director, Head, Liver Disease Program Novartis Institute for BioMedical Research, Roberto Calle Executive Director, Internal Medicine Research Unit Pfizer, Richard Marshall Chief Medical Officer Galecto Biotech, Saswata Talukdar Director – CardioMetabolic Discovery Merck, Saurabh Gupta Director – Translational Research & Early Clinical Takeda, Stephen Previs Director Merck, Suneil Hosmane Executive Vice President- Strategic Development Genfit, Star Seyedkazemi Associate Vice President in Clinical Development Allergan, Wayne Eskridge Chief Executive Officer Fatty Liver Foundation, Weilin Xie Senior Principal Scientist Celgene, Yury Popov Assistant Professor of Medicine Harvard Medical School
  • Health
Organizer phone:+1 617 455 4188
Offering type:Data not provided
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade
Est. # of exhibitors:
Currency:US Dollars
Language:Data not provided
CE Credits:
Organizer URL


Be at the forefront of the insights from 60+ leading experts as they share their learnings on:

Commercialization challenges, the payers perspective and the investors’ criteria for business in the current and future NASH market

The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials

Computational methods and artificial intelligence to increase the efficiency of drug development

Scientific rationale of combinational therapeutics as the necessary treatment strategy for NASH to inform pairing decisions

Identification and recruitment of “high risk” patients needed to optimize clinical success and demonstrate sufficient efficacy


8:00 am to 5:00 pm

Registration Fee Details:

Gold Pass: Full Access (Conference Days + Seminar Day & Discussion Day): USD 4597.0,
Silver Pass: Conference + Seminar Day: USD 3898.0,
Silver Pass: Conference + Discussion Day (2 Workshops): USD 3898.0,
Bronze Pass: Conference Only: USD 2899.0,
Bronze Pass: Seminar Day Only: USD 1399.0,
Bronze Pass: Discussion Day Only (2 Workshops): USD 1399.0

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Georgina FitzGerald
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+1 617 455 4188
Structural makeupData not provided
Host Sponsor; Other SponsorsHanson Wade
Event Site/VenueHilton Boston Logan Airport
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:


Sign In/Sign Out
About Us
Contact Us